Thursday marks the official start of the 2001 annual International Genome Sequencing and Analysis Conference in San Diego.

The meeting, in its 13th year, will host about 3,000 attendees from industry, academia, and government, and some 140 private and public companies. It wraps on Sunday.

Leading GSAC this year are co-chairs Dennis Hochstrasser, from Geneva University Hospital; Yusuke Nakamura, from the University of Tokyo; and J. Craig Venter, from Celera Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.